Ruoyun Wang

ORCID: 0000-0003-2230-0728
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Child and Adolescent Psychosocial and Emotional Development
  • Child and Adolescent Health
  • Digital Mental Health Interventions
  • Cervical Cancer and HPV Research
  • Emergency and Acute Care Studies
  • Vaccine Coverage and Hesitancy
  • Suicide and Self-Harm Studies
  • Mobile Health and mHealth Applications
  • COVID-19 and Mental Health
  • Colorectal Cancer Treatments and Studies
  • Health Policy Implementation Science
  • Mental Health Research Topics
  • Adolescent and Pediatric Healthcare
  • Abdominal Surgery and Complications
  • Cancer, Stress, Anesthesia, and Immune Response
  • Ethics in Clinical Research
  • Non-Invasive Vital Sign Monitoring
  • Wireless Power Transfer Systems
  • Cancer Immunotherapy and Biomarkers
  • Respiratory viral infections research
  • Genital Health and Disease
  • Mental Health Treatment and Access

Washington University in St. Louis
2021-2024

University of Leeds
2022

Wenzhou Medical University
2022

First Affiliated Hospital of Wenzhou Medical University
2022

Symptoms of depression and anxiety, suicidal ideation, self-harm have escalated among adolescents to crisis levels during the COVID-19 pandemic. As a result, primary care providers (PCPs) are often called on provide first-line for these youth. Digital health interventions can extend mental specialty care, but few evidence based. We evaluated feasibility delivering an evidence-based mobile (mHealth) app with embedded conversational agent deliver cognitive behavioral therapy (CBT) symptomatic...

10.2196/40242 article EN cc-by JMIR Formative Research 2022-10-25

BACKGROUND Few adolescents with depression receive treatment in accordance national guidelines. This quality improvement project took place 11 primary care practices the aim of increasing percentage teens who received follow-up within 6 weeks diagnosis and 3 months, once stable. METHODS The strategy was external practice facilitation for 12 months. change process used goal setting plan-do-study-act cycles to identify implement ideas. A preanalysis postanalysis completed evaluate change,...

10.1542/peds.2021-051107 article EN PEDIATRICS 2022-05-10

Given the increase in youth mental health concerns, American Academy of Pediatrics (AAP) recommends universal suicide screening for ages 12 and older, with positive screens followed by a brief risk assessment. However, it is unclear how pediatric clinicians incorporate this recommendation into practice. Therefore, objective qualitative study was to identify clinicians' current practice, attitudes, barriers implement updated primary care.

10.1177/21501319241271321 article EN cc-by-nc Journal of Primary Care & Community Health 2024-01-01

The St Louis Regional Pediatric Learning Collaborative of pediatric primary care providers and infectious diseases specialists formed in March 2020 to address the needs children families during coronavirus disease 2019 (COVID-19) pandemic. More than 400 participated, using a listserv discuss organize webinars provide updates on local national data plan next steps. To inform decision-making about testing for severe acute respiratory syndrome 2, 95 from 26 practices partnered with...

10.1542/peds.2021-052106 article EN PEDIATRICS 2021-07-07

<sec> <title>BACKGROUND</title> Depression, anxiety and related suicidal ideation self-harm are common among adolescents, have increased in prevalence severity during the pandemic to crisis levels, exacerbated by long-standing workforce shortage of child mental health professionals. As a result, primary care providers often called on provide first-line for these youth. Digital interventions extend specialty youth with moderately severe symptoms, but few evidence-based. Here, we describe...

10.2196/preprints.40242 preprint EN 2022-06-12

Pembrolizumab is a humanized anti-PD1 monoclonal antibody that has been approved for immunotherapy of malignant melanoma, classical hodgkin lymphoma, non-small cell lung cancer, etc. However, the toxicity pembrolizumab demonstrated in preclinical and clinical studies. The main side effects are related to activation various immune cells body. triggered system may attack healthy organs, such as livers, lungs kidneys. resulting toxic reactions can cause varying degrees damage patient's body...

10.54097/hset.v6i.972 article EN cc-by-nc Highlights in Science Engineering and Technology 2022-07-27
Coming Soon ...